Biohaven Delivers Positive Phase 3 Results With Rimegepant Zydis® Orally Dissolving Tablet (ODT)




Catalent welcomes Biohaven’s announcement that it has Delivered Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine

Learn More